ArticleCancers2023

CTTN Overexpression Confers Cancer Stem Cell-like Properties and Trastuzumab Resistance via DKK-1/WNT Signaling in HER2 Positive Breast Cancer.

So-Jeong Moon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.